Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Evaluation of Cytotoxic and Genotoxic Effects of Extremely Low-frequency Electromagnetic Field on Mesenchymal Stromal Cells.

Ross CL, Pettenati MJ, Procita J, Cathey L, George SK, Almeida-Porada G.

Glob Adv Health Med. 2018 May 18;7:2164956118777472. doi: 10.1177/2164956118777472. eCollection 2018.

2.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor.

Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.

Case Rep Nephrol. 2015;2015:821346. doi: 10.1155/2015/821346. Epub 2015 Apr 21.

3.

Clinicopathological analysis of near-tetraploidy/tetraploidy acute myeloid leukaemia.

Pang CS, Pettenati MJ, Pardee TS.

J Clin Pathol. 2015 Mar;68(3):236-40. doi: 10.1136/jclinpath-2014-202697. Epub 2015 Jan 6.

4.

MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.

Ware PL, Snow AN, Gvalani M, Pettenati MJ, Qasem SA.

Am J Clin Pathol. 2014 Mar;141(3):334-41. doi: 10.1309/AJCPLYU89XHSNHQO.

PMID:
24515760
5.

Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature.

Naik S, Tayapongsak K, Robbins K, Manavi CK, Pettenati MJ, Grier DD.

Case Rep Oncol. 2013 Jan;6(1):6-14. doi: 10.1159/000346346. Epub 2013 Jan 8.

6.

New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.

Walker A, Mrózek K, Kohlschmidt J, Rao KW, Pettenati MJ, Sterling LJ, Marcucci G, Carroll AJ, Bloomfield CD; Alliance for Clinical Trials in Oncology.

Genes Chromosomes Cancer. 2013 Apr;52(4):385-401. doi: 10.1002/gcc.22036. Epub 2012 Dec 10.

7.

inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.

Schwind S, Edwards CG, Nicolet D, Mrózek K, Maharry K, Wu YZ, Paschka P, Eisfeld AK, Hoellerbauer P, Becker H, Metzeler KH, Curfman J, Kohlschmidt J, Prior TW, Kolitz JE, Blum W, Pettenati MJ, Dal Cin P, Carroll AJ, Caligiuri MA, Larson RA, Volinia S, Marcucci G, Bloomfield CD; Alliance for Clinical Trials in Oncology.

Blood. 2013 Jan 10;121(2):385-91. doi: 10.1182/blood-2012-07-442772. Epub 2012 Nov 16.

8.

Pdx1 and controlled culture conditions induced differentiation of human amniotic fluid-derived stem cells to insulin-producing clusters.

Chun SY, Mack DL, Moorefield E, Oh SH, Kwon TG, Pettenati MJ, Yoo JJ, Coppi PD, Atala A, Soker S.

J Tissue Eng Regen Med. 2015 May;9(5):540-9. doi: 10.1002/term.1631. Epub 2012 Nov 13.

9.

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

Mrózek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu YZ, Kohlschmidt J, Pettenati MJ, Heerema NA, Block AW, Patil SR, Baer MR, Kolitz JE, Moore JO, Carroll AJ, Stone RM, Larson RA, Bloomfield CD.

J Clin Oncol. 2012 Dec 20;30(36):4515-23. doi: 10.1200/JCO.2012.43.4738. Epub 2012 Sep 17.

10.

The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies.

Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, Grubert F, Erdman C, Gao MC, Lange K, Sobel EM, Barlow GM, Aylsworth AS, Carpenter NJ, Clark RD, Cohen MY, Doran E, Falik-Zaccai T, Lewin SO, Lott IT, McGillivray BC, Moeschler JB, Pettenati MJ, Pueschel SM, Rao KW, Shaffer LG, Shohat M, Van Riper AJ, Warburton D, Weissman S, Gerstein MB, Snyder M, Korenberg JR.

Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12031-6. doi: 10.1073/pnas.0813248106. Epub 2009 Jul 13.

11.

Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experience.

Mrózek K, Carroll AJ, Maharry K, Rao KW, Patil SR, Pettenati MJ, Watson MS, Arthur DC, Tantravahi R, Heerema NA, Koduru PR, Block AW, Qumsiyeh MB, Edwards CG, Sterling LJ, Holland KB, Bloomfield CD.

Int J Oncol. 2008 Aug;33(2):239-44.

12.

Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors.

Dance-Barnes ST, Kock ND, Floyd HS, Moore JE, Mosley LJ, D'Agostino RB Jr, Pettenati MJ, Miller MS.

Toxicol Appl Pharmacol. 2008 Aug 15;231(1):77-84. doi: 10.1016/j.taap.2008.04.014. Epub 2008 Apr 27.

13.

Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney.

Brownlee NA, Perkins LA, Stewart W, Jackle B, Pettenati MJ, Koty PP, Iskandar SS, Garvin AJ.

Arch Pathol Lab Med. 2007 Mar;131(3):446-51.

PMID:
17516747
14.

Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.

Chauvenet AR, Martin PL, Devidas M, Linda SB, Bell BA, Kurtzberg J, Pullen J, Pettenati MJ, Carroll AJ, Shuster JJ, Camitta B.

Blood. 2007 Aug 15;110(4):1105-11. Epub 2007 Apr 18.

15.

Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.

Heerema NA, Raimondi SC, Anderson JR, Biegel J, Camitta BM, Cooley LD, Gaynon PS, Hirsch B, Magenis RE, McGavran L, Patil S, Pettenati MJ, Pullen J, Rao K, Roulston D, Schneider NR, Shuster JJ, Sanger W, Sutcliffe MJ, van Tuinen P, Watson MS, Carroll AJ.

Genes Chromosomes Cancer. 2007 Jul;46(7):684-93.

16.

Diagnostic pitfalls associated with fine-needle aspiration biopsy in a patient with the myxoid variant of monophasic fibrous synovial sarcoma.

Bergman S, Brownlee NA, Geisinger KR, Ward WG, Pettenati MJ, Koty P, Ellis E, Beaty MW, Kilpatrick SE.

Diagn Cytopathol. 2006 Nov;34(11):761-7.

PMID:
17121200
17.

Transferable anticancer innate immunity in spontaneous regression/complete resistance mice.

Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir HM, Du W, Kim J, Simpson AJ, Old LJ, Cui Z.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7753-8. Epub 2006 May 8.

18.

Addition of sargramostim (GM-CSF) to imatinib results in major cytogenetic response in a patient with chronic myeloid leukemia.

Connor RF, Hurd D, Pettenati MJ, Koty P, Molnár I.

Leuk Res. 2006 Oct;30(10):1249-52. Epub 2006 Mar 31.

PMID:
16580068
19.

The usefulness of cytogenetic analysis in fine needle aspirates for the histologic subtyping of sarcomas.

Kilpatrick SE, Bergman S, Pettenati MJ, Gulley ML.

Mod Pathol. 2006 Jun;19(6):815-9.

20.

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

Cancer and Leukemia Group B 8461, Farag SS, Archer KJ, Mrózek K, Ruppert AS, Carroll AJ, Vardiman JW, Pettenati MJ, Baer MR, Qumsiyeh MB, Koduru PR, Ning Y, Mayer RJ, Stone RM, Larson RA, Bloomfield CD.

Blood. 2006 Jul 1;108(1):63-73. Epub 2006 Mar 7.

21.

Primary pleuropulmonary synovial sarcoma diagnosed by fine needle aspiration with cytogenetic confirmation: a case report.

Taylor CA, Barnhart A, Pettenati MJ, Geisinger KR.

Acta Cytol. 2005 Nov-Dec;49(6):673-6.

PMID:
16450912
22.

Diagnosis of Burkitt lymphoma in pediatric patients by thoracentesis.

McLean TW, Farber RS, Lewis ZT, Wofford MM, Pettenati MJ, Pranikoff T, Chauvenet AR.

Pediatr Blood Cancer. 2007 Jul;49(1):90-2.

PMID:
16302222
23.

Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.

Marcucci G, Mrózek K, Ruppert AS, Maharry K, Kolitz JE, Moore JO, Mayer RJ, Pettenati MJ, Powell BL, Edwards CG, Sterling LJ, Vardiman JW, Schiffer CA, Carroll AJ, Larson RA, Bloomfield CD.

J Clin Oncol. 2005 Aug 20;23(24):5705-17.

PMID:
16110030
24.

Polyploid formation via chromosome duplication induced by CTP:phosphocholine cytidylyltransferase deficiency and Bcl-2 overexpression: identification of two novel endogenous factors.

Shen YJ, DeLong CJ, Tercé F, Kute T, Willingham MC, Pettenati MJ, Cui Z.

J Histochem Cytochem. 2005 Jun;53(6):725-33.

PMID:
15928321
25.

Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.

Farag SS, Ruppert AS, Mrózek K, Mayer RJ, Stone RM, Carroll AJ, Powell BL, Moore JO, Pettenati MJ, Koduru PR, Stamberg J, Baer MR, Block AW, Vardiman JW, Kolitz JE, Schiffer CA, Larson RA, Bloomfield CD.

J Clin Oncol. 2005 Jan 20;23(3):482-93. Epub 2004 Nov 8.

PMID:
15534356
26.

Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.

Blum W, Mrózek K, Ruppert AS, Carroll AJ, Rao KW, Pettenati MJ, Anastasi J, Larson RA, Bloomfield CD.

Cancer. 2004 Sep 15;101(6):1420-7. Review.

27.

Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.

Farag SS, Ruppert AS, Mrózek K, Carroll AJ, Pettenati MJ, Le Beau MM, Peterson BL, Powell BL, Ozer H, Silver RT, Larson RA, Bloomfield CD; Cancer and Leukemia Group B study.

Int J Oncol. 2004 Jul;25(1):143-51.

PMID:
15201999
28.

Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.

Marcucci G, Mrózek K, Ruppert AS, Archer KJ, Pettenati MJ, Heerema NA, Carroll AJ, Koduru PR, Kolitz JE, Sterling LJ, Edwards CG, Anastasi J, Larson RA, Bloomfield CD.

J Clin Oncol. 2004 Jun 15;22(12):2410-8.

PMID:
15197203
29.

Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.

Bloomfield CD, Ruppert AS, Mrózek K, Kolitz JE, Moore JO, Mayer RJ, Edwards CG, Sterling LJ, Vardiman JW, Carroll AJ, Pettenati MJ, Stamberg J, Byrd JC, Marcucci G, Larson RA; Cancer and Leukemia Group B (CALGB) Study 8461.

Ann Hematol. 2004;83 Suppl 1:S84-5. No abstract available.

PMID:
15124687
31.

Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.

Byrd JC, Ruppert AS, Mrózek K, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Stamberg J, Koduru PR, Moore JO, Mayer RJ, Davey FR, Larson RA, Bloomfield CD.

J Clin Oncol. 2004 Mar 15;22(6):1087-94.

PMID:
15020610
33.

Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: a case report emphasizing the cytological and cytogenetic findings.

Jhala DN, Eltoum I, Carroll AJ, Lopez-Ben R, Lopez-Terrada D, Rao PH, Pettenati MJ, Siegal GP.

Hum Pathol. 2003 Dec;34(12):1354-7.

PMID:
14691924
34.

Ring chromosome 17: phenotype variation by deletion size.

Shashi V, White JR, Pettenati MJ, Root SK, Bell WL.

Clin Genet. 2003 Oct;64(4):361-5.

PMID:
12974742
35.

Inflammatory myofibroblastic tumor with bone marrow involvement. A case report and review of the literature.

Hagenstad CT, Kilpatrick SE, Pettenati MJ, Savage PD.

Arch Pathol Lab Med. 2003 Jul;127(7):865-7. Review.

PMID:
12823044
36.

Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant.

Zamkoff KW, Bergman S, Beaty MW, Buss DH, Pettenati MJ, Hurd DD.

Bone Marrow Transplant. 2003 Feb;31(3):219-22.

PMID:
12621485
37.

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).

Byrd JC, Mrózek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson MS, Koduru PR, Moore JO, Stone RM, Mayer RJ, Feldman EJ, Davey FR, Schiffer CA, Larson RA, Bloomfield CD; Cancer and Leukemia Group B (CALGB 8461).

Blood. 2002 Dec 15;100(13):4325-36. Epub 2002 Aug 1.

38.

Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

Farag SS, Archer KJ, Mrózek K, Vardiman JW, Carroll AJ, Pettenati MJ, Moore JO, Kolitz JE, Mayer RJ, Stone RM, Larson RA, Bloomfield CD.

Int J Oncol. 2002 Nov;21(5):1041-51.

PMID:
12370753
39.

Unexpected retention and concomitant loss of subtelomeric regions in balanced chromosome anomalies by FISH.

Pettenati MJ, Jackle B, Bobby P, Stewart W, Von Kap-Herr C, Mowrey P, Rao PN, May KM.

Am J Med Genet. 2002 Jul 22;111(1):48-53.

PMID:
12124733
40.

Biochemical and mutational analyses of the cathepsin c gene (CTSC) in three North American families with Papillon Lefèvre syndrome.

Zhang Y, Hart PS, Moretti AJ, Bouwsma OJ, Fisher EM, Dudlicek L, Pettenati MJ, Hart TC.

Hum Mutat. 2002 Jul;20(1):75.

PMID:
12112662
41.

Localization, genomic organization, and alternative transcription of a novel human SAM-dependent methyltransferase gene on chromosome 2p22-->p21.

Zhang Y, Gorry MC, Hart PS, Pettenati MJ, Wang L, Marks JJ, Lu X, Hart TC.

Cytogenet Cell Genet. 2001;95(3-4):146-52.

PMID:
12063391
42.

Rapid interphase analysis for prenatal diagnosis of translocation carriers using subtelomeric probes.

Pettenati MJ, Von Kap-Herr C, Jackle B, Bobby P, Mowrey P, Schwartz S, Rao PN, Rosnes J.

Prenat Diagn. 2002 Mar;22(3):193-7.

PMID:
11920892
43.

Primary malignant lymphoma of uterine corpus: case report and review of the literature.

Renno SI, Moreland WS, Pettenati MJ, Beaty MW, Keung YK.

Ann Hematol. 2002 Jan;81(1):44-7. Epub 2001 Dec 13.

PMID:
11807635
44.

The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein.

Pierce RA, Field ED, Mutis T, Golovina TN, Von Kap-Herr C, Wilke M, Pool J, Shabanowitz J, Pettenati MJ, Eisenlohr LC, Hunt DF, Goulmy E, Engelhard VH.

J Immunol. 2001 Sep 15;167(6):3223-30.

45.

Prenatal diagnosis of complete sole trisomy 1q.

Pettenati MJ, Berry M, Shashi V, Hartley Bowen J, Harper M.

Prenat Diagn. 2001 Jun;21(6):435-40. Review.

PMID:
11438944
46.

Maternal homozygosity for the common MTHFR mutation as a potential risk factor for offspring with limb defects.

Shashi V, Rickheim A, Pettenati MJ.

Am J Med Genet. 2001 Apr 15;100(1):25-9.

PMID:
11337744
47.

Detection of mosaicism in amniotic fluid cultures: a CYTO2000 collaborative study.

Ing PS, Van Dyke DL, Caudill SP, Reidy JA, Bice G, Bieber FR, Buchanan PD, Carroll AJ, Cheung SW, DeWald G, Donahue RP, Gardner HA, Higgins J, Hsu LY, Jamehdor M, Keitges EA, Laundon CH, Luthardt FW, Mascarello J, May KM, Meck JM, Morton C, Patil S, Peakman D, Pettenati MJ, Rao N, Sanger WG, Saxe DF, Schwartz S, Sekhon GS, Vance GH, Wyandt HE, Yu CW, Zenger-Hain J, Chen AT.

Genet Med. 1999 Mar-Apr;1(3):94-7.

PMID:
11336459
48.

Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.

Mrózek K, Prior TW, Edwards C, Marcucci G, Carroll AJ, Snyder PJ, Koduru PR, Theil KS, Pettenati MJ, Archer KJ, Caligiuri MA, Vardiman JW, Kolitz JE, Larson RA, Bloomfield CD.

J Clin Oncol. 2001 May 1;19(9):2482-92.

PMID:
11331327
49.

Prenatal diagnosis using interphase fluorescence in situ hybridization (FISH): 2-year multi-center retrospective study and review of the literature.

Tepperberg J, Pettenati MJ, Rao PN, Lese CM, Rita D, Wyandt H, Gersen S, White B, Schoonmaker MM.

Prenat Diagn. 2001 Apr;21(4):293-301. Review.

PMID:
11288120
50.

Down syndrome congenital heart disease: a narrowed region and a candidate gene.

Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ, Vekemans MJ, Mjaatvedt CH, Korenberg JR.

Genet Med. 2001 Mar-Apr;3(2):91-101.

PMID:
11280955

Supplemental Content

Loading ...
Support Center